<DOC>
	<DOCNO>NCT01294969</DOCNO>
	<brief_summary>To evaluate patient perception Al-4943 subject allergic conjunctivitis previously treat topical ocular anti-allergy leukotriene-release inhibitor medication .</brief_summary>
	<brief_title>Patient Perception Study AL-4943A</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>History allergic conjunctivitis within last 24 month Active sign symptom ocular allergy Severe serious ocular condition , ocular surgical intervention , ocular infection</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Allergic conjunctivitis</keyword>
</DOC>